The Influence of Sperm Morphology and Functional Indices on Blastocyst Development in Assisted Reproduction
NCT ID: NCT06801652
Last Updated: 2025-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2023-10-21
2024-11-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of the Number of Inseminated Spermatozoa on Subsequent Human Embryonic Development in Vitro
NCT00710476
In Vitro Maturation of Human Eggs
NCT02516462
Sperm DNA Fragmentation Effects on Blastocyst Morphology Grading, Pregnancy Rate and Implantation Rate
NCT04144621
Does DNA Sperm Fragmentation Affects Embryo Morphokinetic?
NCT02214537
Study of Abnormally Fertilized Embryos
NCT06940973
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Positive HCG pregnancy test after embryotransfer
Patients with sperm morphology indexes analyzed and had at least one good quality blastocyst that had a Positive HCG pregnancy test after embryo-transfer.
Sperm morphology indexes
We analyzed all sperm morphology indexes in all groups.
Negative HCG pregnancy test after embryotransfer
Patients with sperm morphology indexes analyzed and had at least one good quality blastocyst that had a Negative HCG pregnancy test after embryo-transfer.
Sperm morphology indexes
We analyzed all sperm morphology indexes in all groups.
No embryo obtained after IVF
Patients with sperm morphology indexes analyzed and had no blastocyst in day 5 or 6 after ICSI-IVF.
Sperm morphology indexes
We analyzed all sperm morphology indexes in all groups.
All embryos obtained are aneuploid
Patients with sperm morphology indexes analyzed and had all blastocyst of day 5/6 tested and aneuployd after ICSI-IVF.
Sperm morphology indexes
We analyzed all sperm morphology indexes in all groups.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sperm morphology indexes
We analyzed all sperm morphology indexes in all groups.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* uterine abnormalities
21 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Calla IVF Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Calla Ivf Center
Oradea, Bihor County, Romania
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CALLA TERATOZOOSPERMIA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.